… , an Oral, Non-opioid, AAK1 Inhibitor for Diabetic Peripheral Neuropathic Pain (DPNP)—Results from a Phase 2b, Dose-Ranging, Randomized, Multicenter Study
用户wKs9XOBeE0CU
1小时前
14
10
已关闭
DOI:
文献链接:
其他信息:
R Pop-Busui, S Gopinathan, MB Hardin…
Diabetes, 2025
diabetesjournals.org
… Methods: PROGRESS was a phase 2b study evaluating the efficacy and safety of pilavapadin
(LX9211), a non-opioid inhibitor of adaptor-associated kinase 1 (AAK1), in adults with T1D …

